Exhibit 99.1
(MISONIX LOGO)
     
Misonix Contact:
  Investor Relations Contact:
Richard Zaremba
  Kevin McGrath, Cameron Associates, Inc.
631-694-9555
  212-245-4577
invest@misonix.com
  Kevin@cameronassoc.com
Misonix Reports Third Quarter and Nine Months Fiscal 2011 Financial Results
FARMINGDALE, NY — May 10 , 2011 —
Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, today reported financial results for the third fiscal quarter and nine months ending March 31, 2011. Michael A. McManus Jr., President and Chief Executive Officer, and Richard Zaremba, Senior Vice President and Chief Financial Officer, will host a conference call Tuesday, May 10, 2011 at 11:30 am to discuss the Company’s third quarter and nine month results.
The Company also reported the following financial and operational achievements:
   
8.5% and 13% increase in revenue for the three and nine months ending March 31, 2011, respectively, compared with the same period ending March 31, 2010.
 
   
Medical device products revenue increased 20% and 21% for the three and nine months ending March 31, 2011, respectively, compared with the same period ending March 31, 2010.
 
   
Gross profit as a percentage of revenue was 52.1% and 52.6% for the three and nine months ending March 31, 2011, respectively.
Revenue for the three months ended March 31, 2011 was $3.6 million, an 8.5% increase when compared with $3.3 million for the same period in fiscal 2010. Medical device products sales increased $518,000 or 19.7% to $3.2 million and laboratory and scientific product sales decreased $238,000 to $440,000 for the three months ended March 31, 2011. The increase in medical device products sales was primarily attributable to sales of the Company’s AutoSonix™, Wound Debrider and Neuroaspirator products.
Gross profit as a percentage of sales (gross profit percentage) was 52.1% for the three months ended March 31, 2011 compared to 51.8% for the three months ended March 31, 2010. Gross profit percentage for medical device products sales was 55.7% for the three months ended March 31, 2011 compared to 57.7% for the three months ended March 31, 2010. Gross profit percentage for medical device products sales was unfavorably impacted in the three months ended March 31, 2011 by the sale of the higher cost Neuroaspirator products purchased from Aesculap, Inc. in October 2010. Gross profit for laboratory and scientific product sales decreased to 26.5% for the three months ended March 31, 2011 from 29.1% for the three months ended March 31, 2010 primarily due to reduced sales volume.

 

1


The following information was filed by Misonix Inc (MSON) on Tuesday, May 10, 2011 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Misonix Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Misonix Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account